At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories. That it depends thereby less on large names, but on the future potential and whether the market also recognizes these perspectives, was one of its first learnings at the stock exchange.
On these pages, Nico examines current events at listed companies and takes a closer look at companies that are traded under the radar of the market, in addition to well-known securities.
In order to be able to take advantage of speculative opportunities on the stock exchange, Nico not only focuses on a balanced asset allocation of defensive and opportunity-oriented securities, but also on an intact risk management. "In addition to position size and entry in several tranches, investors should also develop a sense of timing and get to know a stock better before investing," says the columnist.
Commented by Nico Popp
Commented by Nico Popp on December 8th, 2022 | 09:05 CET
Where the money is made: BioNTech, Novavax, Cardiol Therapeutics
While the first federal states in Germany are lifting the mask requirement on public transport, suppliers of vaccines and medicines are far from going back to normal. Even corona vaccines are in high demand. While there is a shortage of antipyretics and medication in this country, especially for children, innovative companies are already addressing the next challenges. We explain where investors can make money.
Read
Commented by Nico Popp on December 7th, 2022 | 09:45 CET
Volkswagen, Altech Advanced Materials, NIO: Where does the starting signal come from?
The whole world is currently investing in renewable energy and storage solutions. Germany, in particular, is considered a pioneer when it comes to promoting environmentally friendly energy sources. However, it looks as if other regions, such as Asia and North America, are overtaking Europe. We look at what the current situation means for investors and which companies can profit regardless of the situation in Germany.
Read
Commented by Nico Popp on December 5th, 2022 | 10:36 CET
Where gold shines brightest: Barrick Gold, Desert Gold, Uniper
Secretly and quietly, gold has stalked towards the USD 1,800 mark. The reasons are the weaker dollar in combination with a possible end of the interest rate turnaround and the growing uncertainty: Even if current economic data, such as the recently published US labor market report, give hope, the risks are growing in the long term. We look at two exciting gold stocks and use the example of Uniper to explain why gold could soon be booming.
Read
Commented by Nico Popp on December 5th, 2022 | 10:14 CET
Investment stories that inspire: Freyr Battery, Manuka Resources, BASF
In order to be successful with stocks in the current market situation, a thorough analysis of companies and their business models is required. Blanket instructions for action do not lead to success. Investment strategies such as the value approach and the focus on unconditional growth are not guaranteed to lead to success. What matters now are convincing investment stories! We take a look at three stocks that are currently in focus and check their future.
Read
Commented by Nico Popp on November 30th, 2022 | 13:33 CET
Advances in the fight against cancer: Arcus Biosciences, Gilead Sciences, Defence Therapeutics, BioNTech
Research studies from 2020 show that 72% of Germans fear cancer. However, very few people want to admit to these fears. But precisely because the subject is a big taboo, it is worth looking at the latest achievements in research. Many companies worldwide have long been fighting the epidemic - and making astonishing progress. Just recently, a US biotech announced encouraging study results. Other companies have yet to launch promising studies. We provide an overview and outline opportunities from an investor's perspective.
Read
Commented by Nico Popp on November 29th, 2022 | 12:20 CET
China as a risk factor? Here is how it looks: Uniper, TubeSolar, BASF
China has repeatedly been a source of risk in recent years: We think of the real estate bubble or the trade war with the US. Now, one of China's supposed plus points could become a risk factor: the authoritarian central regime in Beijing. In just four minutes, we explain what the nationwide protests against Chinese lockdowns mean and how investors can use foresight to gain information advantages.
Read
Commented by Nico Popp on November 28th, 2022 | 12:25 CET
Is this patent causing a rare earths quake? Nordex, Defense Metals, BYD
Wind power is a crucial component of the energy transition. Rare earths are used to increase the efficiency of wind turbines and electric motors. Dysprosium and terbium, in particular, are in demand. But although rare earths are anything but rare, they are only found in a few regions worldwide. Scientists at Darmstadt Technical University have now developed processes to use rare earths more efficiently. We explain the technology and shed light on three stocks related to rare earths.
Read
Commented by Nico Popp on November 24th, 2022 | 11:12 CET
What the heat turnaround means for copper: Siemens Energy, Kodiak Copper, ThyssenKrupp
Investors looking for the latest trends often focus on metals such as rare earths, vanadium and lithium. But if you want to get the future into your portfolio, you don't have to rely on exotic elements; copper offers the best conditions. As the British Building Services Research and Information Association (BSRIA) has shown on behalf of the International Copper Association, the demand for copper alone for climate-related refurbishment will increase to 160,000t by 2035 from the current 40,000t. That represents an annual growth rate of around 10%. We highlight three companies around the trend.
Read
Commented by Nico Popp on November 22nd, 2022 | 10:44 CET
Batteries: The new premium class - BYD, Almonty Industries, Varta
When it comes to everyday products, we all have clear ideas about prices. For a long time, the EUR 2 mark, for example, was considered an average price for a piece of butter. But as soon as it becomes more expensive, it is worth a headline in a newspaper with big letters. It is a different story with cars or other high-quality products. Thanks to high-quality workmanship and technology, customers are willing to pay more than the actual market prices. In economics, the difference between the high price and the market price is called producer surplus. We present three companies that want to skim off this producer surplus.
Read
Commented by Nico Popp on November 21st, 2022 | 12:11 CET
Biotech - Hotter than ever: Catalyst Pharmaceuticals, BioNxt Solutions, Bayer
Biotechs have been providing answers to humanity's most pressing questions for years. Innovative companies are applying advanced methods to make a medical difference. The example of BioNTech is just one success story among many. While companies in the pharmaceutical sector are finding it increasingly difficult to come up with real innovations, biotechs often put all their eggs in one basket - and win. We present two biotech hopefuls and take a look at Bayer.
Read